Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.29%, DAX +0.34%, CAC +0.18%

Aug 13 ,2026

  • Synopsis

    • European equity markets are set to open in positive territory amidst Asia equities trading broadly higher Thursday. South Korea rallying, followed by sharp gains in Japan's Nikkei and Taiwan on the back of tech strength. Mainland China tracking moderate gains, Hong Kong marginally higher, while Australia lagging. US futures steadied in Asia following some earlier weakness in Nasdaq. Follows mostly higher performance in the cash session in a generally uneventful session consistent with the summer holiday period.

    • Overnight attention was concentrated on US CPI, where in-line headline metrics confirmed expectations of easing inflation pressure, dovetailing with earlier weak employment data. September Fed rate hike odds declined to 40%. Latest dollar strength essentially erased earlier selling pressure into the CPI release.

    • Back in Europe, in central banks, Norges Bank interest rate decision at 10:00CET. The benchmark interest rate is expected to be increased +25bps to 4.5%, though last month's slowing of core inflation has led some commentators to expect no change. The decision on the countercyclical capital buffer rate will be published at the same time. In politics, in the UK, there's the Clacton-on-Sea by-election. Reform UK Party's Farage looking to get re-elected in what he has termed 'people versus the establishment' vote. Whilst all the major parties, including the Conservatives, Labour and Liberal Democrats, have decided not to field a candidate, there are 34 names on the ballot paper - though independent candidate Abi Hookway has stated she will not be actively standing, with the previous record for a House of Commons seat being 28 candidates. Recent Survation poll showed Farage leading on 73% with Count Binface next on 20%. In Norway, there's the political party leaders debate at 19:40CET at Arendal Week, this will be televised on NRK

    • Macroeconomic data due today include: Switzerland Jul PPI, Spain Jul final CPI, Eurozone Jun industrial production, UK Q2 preliminary GDP, Jul house price balance - RICS, monthly GDP tracker - NIESR, Jun industrial/manufacturing production, trade balance, construction output, Ireland Jul CPI.

    • A busy earnings calendar dominated. In the DACH region, HelloFresh (HFG.GR) reported Q2 earnings and specified its FY guidance, while ThyssenKrupp (TKA.GR) narrowed its FY26 forecast. Freenet (FNTN.GR) confirmed guidance. RWE (RWE.GR) confirmed preliminary H1 numbers along with FY26 and FY27 guidance and long-term earnings outlook.

    • Out of the Nordics, Pandora (PNDORA.DC) released Q2 numbers and upgraded FY26 guidance yesterday evening. Embracer Group (EMBRAC.B.SS) posted Q2 earnings this morning. Zealand Pharma (ZEAL.DC) Q2 net income beat FactSet with FY26 financial guidance unchanged. DNO ASA (DNO.NO) and AutoStore Holdings (AUTO.NO) are also among the key names reporting. Maersk (MAERSK.B.DC) is also out with its half-year report. From the Netherlands, Adyen (ADYEN.NA) reported H1 earnings and commented on financial objectives.

    • In the UK, Antofagasta (ANTO.LN), Entain (ENT.LN), Savills (SVS.LN), Costain Group (COST.LN) and Rank Group (RNK.LN) are expected to release earnings today.

  • Politics/Macro/World News

    • How Russian attacks, European protectionism and drought are trapping Ukraine's vital grain - Politico

    • Rhine drought exposes 34-year delay in tackling major German bottleneck - FT

    • UK Jul house price balance (30%) vs consensus (31%) and prior revised (32%) from (33%) - RICS

  • Top company news

    • Earnings/updates

      • DACHs

        • HFG.GR (HelloFresh) -- reports Q2 adjusted EBITDA €120.6M vs consensus €121.5M; revenue performance in constant currency is trending towards the bottom end of the 2026 guidance range

        • TKA.GR (ThyssenKrupp) -- reports Q3 adj EBIT €183M vs consensus €207.0M; narrows FY26 forecast

        • FHZN.SW (Flughafen Zuerich) -- reports Jul traffic statistics

        • FNTN.GR (Freenet) -- reports Q2 Adjusted EBITDA €120.2M vs consensus €123.1M; guidance for 2026 financial year and financial targets for 2028 confirmed

        • SQN.SW (Swissquote Group Holding) -- reports H1 net income CHF153.6M vs FactSet CHF165.7M [4 est, CHF145-187M]; Lowers FY guidance, reaffirms 2028 target

        • WAC.GR (Wacker Neuson Group) -- confimrs prelim Q2/H1 eanrings and raised FY26 guidance as per 17-Jul update

        • RWE.GR (RWE) -- confirms preliminary H1 numbers along with FY26 and FY27 guidance and long-term earnings outlook

        • S92.GR (SMA Solar Technology) -- reports final Q2/H! earnings; improvement in sales and earnings expected in H2; reaffirms FY guidance

        • MLP.GR (MLP SE) -- confirms prelim Q2/H1 earnings and FY26 guidance and 2028 mid-term planning as per 29-Jul update

        • V1NC.GR (Vincorion SE) -- reports H1 net income attributable €16.9M vs year-ago €9.8M; expects FY at upper end of guidance ranges

        • SEM.AV (Semperit Holding) -- reports H1 EPS €1.39 vs year-ago (€0.54

        • HLAG.GR (Hapag-Lloyd) -- reports Q2 net income €71M vs FactSet €173.5M [3 est, €72.9-250M]

        • SIX2.GR (Sixt) -- reports Q2 net income €83.0M, +6% vs year-ago €78.4M; FY26 guidance confirmed

        • HHFA.GR (Hamburger Hafen und Logistik) -- reports H1 net income (€4.2M) vs year-ago €19.1M

      • Nordics

        • ZEAL.DC (Zealand Pharma) -- reports Q2 net income DKK3.92B vs FactSet DKK3.44B; FY26 financial guidance is unchanged

        • PNDORA.DC (Pandora) -- reports Q2 net income DKK875M vs consensus DKK634M; upgrades FY26 guidance

        • AUTO.NO (AutoStore Holdings) -- reports Q2 EPS $0.02 vs FactSet $0.01 [5 est, $0.01-0.01]

        • CTY1S.FH (Citycon) -- Oyj reports H1 EPRA EPS €0.14 ex-items vs year-ago €0.14

        • HAYPP.SS (Haypp Group) -- reports Q2 EPS SEK0.00 vs FactSet SEK0.50 [2 est, SEK0.31-0.70] (unclear if comparable)

        • MEKKO.FH (Marimekko) -- set new, medium-term (3-5 years) financial goals; reaffirms long-term financial goals

        • EMBRAC.B.SS (Embracer Group) -- reports Q1 Adjusted EPS SEK1.03 vs FactSet SEK0.32 [5 est, SEK0.17-0.41]

        • LUMO.FH (Lumo Homes) -- reports Q2 FFO €0.16 vs FactSet €0.16; FY outlook specified

        • DNO.NO (DNO ASA) -- reports Q2 net income $83.4M vs FactSet $130.8M [4 est, $75-165M]

        • MANTA.FH (Mandatum) -- reports Q2 EPS €0.13 vs FactSet €0.08 [5 est, €0.06-0.10]

        • RAY.B.SS (RaySearch Laboratories) -- reports Q2 EPS SEK0.57 vs FactSet SEK1.19 [2 est, SEK0.60-1.77]

        • ARCH.NO (Archer) -- reports Q2 net income $0.2M vs year-ago $2.0M

        • MORLD.NO (Moreld) -- reports Q2 EPS NOK0.76 vs year-ago NOK0.77

        • NETC.DC (Netcompany Group) raises FY Group revenue growth to between +16-20.5% vs prior +15-20%; keeps FY adj EBITDA margin guidance unchanged

      • France

        • VLA.FP (Valneva) -- reports H1 net income (€63.3M) vs year-ago (€20.8M); FY guidance reaffirmed

      • Benelux

        • FAST.NA (Fastned) -- reports H1 underlying net income (€15.1M) vs year-ago (€19.9M); increases FY26 operational EBITDA guidance

        • ADYEN.NA (Adyen) -- reports H1 EBITDA €641.5M vs FactSet €642.3M [17 est, €625-678.6M]; comments on financial objectives

    • M&A

      • BFIT.NA (Basic-Fit) -- Basic-fit completes acquisition of WELLYOU

    • Healthcare

      • PHARM.NA (Pharming Group) -- announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with activated PI3K delta syndrome (APDS) aged 4 years and older

    • Other

      • SPM.IM (Saipem) -- announces ~$1.8B offshore contract in the Middle East

      • T0A.GR (Trulieve Cannabis) -- Transcript Intelligence: Trulieve Cannabis at Canaccord Genuity Growth Conference

      • AUTO.NO (AutoStore Holdings) -- enters into strategic supply agreement (without purchase commitments) with Amazon

        • authorizes share buyback of up to $75M

  • Key rating changes

    • Upgrades

      • SPX.LN (Spirax Group) -- to buy from hold at Panmure Liberum

      • TKMS.GR (TKMS AG & Co. KGaA) -- to outperform from market perform at Bernstein

      • JPMorgan upgrades AV.LN

    • Downgrades

      • UMG.NA (Universal Music Group) -- to reduce from hold at HSBC

      • PRY.IM (Prysmian) -- to market perform from outperform at Bernstein

      • LXS.GR (Lanxess) -- to sell from hold at Berenberg

      • JPMorgan downgrades LGEN.LN, MNG.LN

  • Data

    • Nikkei +1.72% to 68685.56

    • Hang Seng +0.17% to 25483.93

    • Shanghai Composite +0.50% to 3966.37

    • S&P futures +8.8 vs prior close of 7770.5

    • €-$ +0.0001 or +0.01% to 1.1526

    • $-¥ (0.06) or (0.04%) to 159.36

    • €-¥ (0.10) or (0.05%) to 183.63

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.